Management of Severe Hypotension in Dialysis Patients
Non-pharmacological strategies should be prioritized first for severe hypotension in dialysis patients, followed by pharmacological interventions like midodrine when necessary. 1
Initial Non-Pharmacological Approaches
Target Weight Assessment
- Reassess the patient's target weight immediately, as an incorrectly low target weight is a common cause of hypotension 1
- Look for signs that the current target weight may be too low:
- Frequent hypotensive episodes during dialysis
- Absence of peripheral edema or pulmonary congestion
- Rapid loss of residual kidney function
- Consider temporarily maintaining the patient slightly above estimated dry weight if hypotension is severe 1
Dialysis Prescription Modifications
- Reduce ultrafiltration rate to below 6 ml/h per kg to minimize risk of end-organ ischemia and mortality 1, 2
- Implement one or more of these strategies:
Timing of Antihypertensive Medications
- Review and adjust timing of antihypertensive medications 1
- Consider withholding antihypertensive medications before dialysis sessions, though evidence for this approach is limited 1
- For patients requiring antihypertensives for cardioprotection, consider administering them at night rather than before dialysis 2
Pharmacological Management
First-Line Medication
- Administer midodrine 5-10 mg orally 30 minutes before dialysis for patients with recurrent severe hypotension 1, 2, 3
- Midodrine has been shown to significantly increase minimal systolic pressure from 93.1 to 107.1 mmHg and post-dialysis blood pressure from 115.6/62.3 to 129.9/68.1 mmHg 3
- Titrate dose based on response (typical range 2.5-25 mg) 3
Alternative Pharmacological Options
For acute severe hypotension during dialysis requiring immediate intervention:
For refractory cases with persistent severe hypotension:
Special Considerations
Patients with Diabetes or Cardiomyopathy
- These patients may require more gradual approaches to fluid removal 2
- For patients with cardiomyopathy, consider carvedilol as the preferred beta-blocker, which has been shown to improve LV function and decrease hospitalization and mortality in dialysis patients 1
Evaluation for Secondary Causes
- If hypotension persists despite above measures, investigate for secondary causes:
- Adrenal insufficiency (check morning cortisol) 7
- Occult blood volume depletion
- Cardiovascular disease (especially cardiomyopathy)
Common Pitfalls to Avoid
- Ignoring target weight assessment - incorrect dry weight is a major contributor to hypotension 1, 2
- Using excessive ultrafiltration rates - rates even as low as 6 ml/h per kg are associated with higher mortality 1
- Allowing food consumption immediately before or during dialysis, which decreases peripheral vascular resistance 2
- Failing to counsel patients on sodium restriction (2-3 g/day), which can reduce interdialytic weight gain 2
- Overlooking medication timing, particularly antihypertensive medications taken shortly before dialysis 1, 2
By systematically addressing these factors, severe hypotension in dialysis patients can be effectively managed while minimizing adverse outcomes related to end-organ hypoperfusion.